|
MX2007005027A
(es)
|
2004-10-26 |
2007-06-19 |
Dolby Lab Licensing Corp |
Calculo y ajuste de la sonoridad percibida y/o el balance espectral percibido de una senal de audio.
|
|
US8563573B2
(en)
|
2007-11-02 |
2013-10-22 |
Vertex Pharmaceuticals Incorporated |
Azaindole derivatives as CFTR modulators
|
|
US20110092554A1
(en)
*
|
2007-11-19 |
2011-04-21 |
Richard Chesworth |
1,3,5 tri-subtituted benzenes for treatment of alzheimer's disease and other disorders
|
|
ME01294B
(me)
|
2007-11-27 |
2013-06-20 |
Ardea Biosciences Inc |
Nova jedinjenja i kompozicije i metode upotrebe
|
|
WO2009086277A1
(en)
|
2007-12-20 |
2009-07-09 |
Envivo Pharmaceuticals, Inc. |
Tetrasubstituted benzenes
|
|
US8242154B2
(en)
|
2008-09-04 |
2012-08-14 |
Ardea Biosciences, Inc. |
Compounds, compositions and methods of using same for modulating uric acid levels
|
|
JP5620392B2
(ja)
*
|
2008-11-03 |
2014-11-05 |
タフツ ユニヴァーシティーＴｕｆｔｓ Ｕｎｉｖｅｒｓｉｔｙ |
クロストリジウム・ディフィシレ胞子の発芽および伸長を阻害するための方法および組成物
|
|
EP2255813A1
(en)
*
|
2009-05-29 |
2010-12-01 |
The Royal College of Surgeons in Ireland |
Derivatives of ursodeoxycholic acid for the treatment of diarrhoea
|
|
PL2519100T3
(pl)
|
2009-12-29 |
2017-09-29 |
Mapi Pharma Limited |
Związki pośrednie i sposoby wytwarzania tapentadolu i pokrewnych związków
|
|
US8802868B2
(en)
|
2010-03-25 |
2014-08-12 |
Vertex Pharmaceuticals Incorporated |
Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
|
|
ES2608474T3
(es)
|
2010-04-22 |
2017-04-11 |
Vertex Pharmaceuticals Incorporated |
Proceso de producción de compuestos indol cycloalkylcarboxamido
|
|
AR081930A1
(es)
|
2010-06-16 |
2012-10-31 |
Ardea Biosciences Inc |
Compuestos de tioacetato
|
|
BR112012032193A2
(pt)
|
2010-06-16 |
2019-09-24 |
Ardea Biosciences Inc |
composto, composiçoes e métodos de uso de feniltioacetato
|
|
US8828994B2
(en)
|
2011-03-08 |
2014-09-09 |
Sanofi |
Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
|
|
EP2766349B1
(de)
|
2011-03-08 |
2016-06-01 |
Sanofi |
Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
WO2012120056A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
EP2683699B1
(de)
|
2011-03-08 |
2015-06-24 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
EP2683704B1
(de)
|
2011-03-08 |
2014-12-17 |
Sanofi |
Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
EP2567959B1
(en)
|
2011-09-12 |
2014-04-16 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
EP3501520A1
(en)
|
2011-11-03 |
2019-06-26 |
Ardea Biosciences, Inc. |
3,4-di-substituted pyridine compound, methods of using and compositions comprising the same
|
|
US9084826B2
(en)
|
2012-05-01 |
2015-07-21 |
Catabasis Pharmaceuticals, Inc. |
Fatty acid conjugates of statin and FXR agonists; compositions and method of uses
|
|
CN103665043B
(zh)
|
2012-08-30 |
2017-11-10 |
江苏豪森药业集团有限公司 |
一种替诺福韦前药及其在医药上的应用
|
|
RS58010B1
(sr)
|
2012-09-27 |
2019-02-28 |
Childrens Medical Ct Corp |
Jedinjenja za lečenje gojaznosti i postupci za njihovu upotrebu
|
|
JP6422452B2
(ja)
|
2013-03-14 |
2018-11-14 |
ユニバーシティ オブ マカオＵｎｉｖｅｒｓｉｔｙ Ｏｆ Ｍａｃａｕ |
ヤクチ（益智（ａｌｐｉｎｉａｅｏｘｙｐｈｙｌｌａｅｆｒｕｃｔｕｓ））およびその全合成から単離される新規な抗神経変性天然化合物
|
|
ES2885181T3
(es)
|
2014-04-15 |
2021-12-13 |
Vertex Pharma |
Composiciones farmacéuticas para el tratamiento de enfermedades mediadas por el regulador de la conductancia transmembrana de fibrosis quística
|
|
WO2016073767A1
(en)
*
|
2014-11-06 |
2016-05-12 |
Enanta Pharmaceuticals, Inc. |
Bile acid analogs an fxr/tgr5 agonists and methods of use thereof
|
|
US11578097B2
(en)
|
2014-11-26 |
2023-02-14 |
Enanta Pharmaceuticals, Inc. |
Tetrazole derivatives of bile acids as FXR/TGR5 agonists and methods of use thereof
|
|
JP2017535570A
(ja)
|
2014-11-26 |
2017-11-30 |
エナンタ ファーマシューティカルズ インコーポレイテッド |
Ｆｘｒ／ｔｇｒ５アゴニストとしての胆汁酸類似体およびその使用方法
|
|
US10208081B2
(en)
|
2014-11-26 |
2019-02-19 |
Enanta Pharmaceuticals, Inc. |
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
|
|
MX2017010376A
(es)
|
2015-02-11 |
2017-12-20 |
Enanta Pharm Inc |
Análogos de ácido biliar como agonistas de fxr/tgr5 y métodos para el uso de los mismos.
|
|
CA2981503C
(en)
|
2015-03-31 |
2023-09-19 |
Enanta Pharmaceuticals, Inc. |
Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
|
|
WO2017147159A1
(en)
|
2016-02-23 |
2017-08-31 |
Enanta Pharmaceuticals, Inc. |
Deuterated bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
|
|
US10323060B2
(en)
|
2016-02-23 |
2019-06-18 |
Enanta Pharmaceuticals, Inc. |
Benzoic acid derivatives of bile acid as FXR/TGR5 agonists and methods of use thereof
|
|
WO2017147174A1
(en)
|
2016-02-23 |
2017-08-31 |
Enanta Pharmaceuticals, Inc. |
Heteroaryl containing bile acid analogs as fxr/tgr5 agonists and methods of use thereof
|
|
DE102017005884A1
(de)
*
|
2016-07-07 |
2018-01-11 |
Merck Patent Gmbh |
Elektronisches Schaltelement
|
|
CA3045023A1
(en)
|
2016-11-29 |
2018-06-07 |
Enanta Pharmaceuticals, Inc. |
Process for preparation of sulfonylurea bile acid derivatives
|
|
US10472386B2
(en)
|
2017-02-14 |
2019-11-12 |
Enanta Pharmaceuticals, Inc. |
Bile acid derivatives as FXR agonists and methods of use thereof
|
|
CA3058754A1
(en)
|
2017-04-07 |
2018-10-11 |
Enanta Pharmaceuticals, Inc. |
Process for preparation of sulfonyl carbamate bile acid derivatives
|
|
DE102018004733A1
(de)
*
|
2018-06-14 |
2019-12-19 |
Merck Patent Gmbh |
Verfahren zur Herstellung eines elektronischen Bauteils enthaltend eine selbstorganisierte Monolage
|
|
CN116925168A
(zh)
|
2019-08-23 |
2023-10-24 |
深圳云合医药科技合伙企业(有限合伙) |
胆汁酸衍生物及其组合物和应用
|
|
US20240391948A1
(en)
*
|
2021-07-26 |
2024-11-28 |
Shaperon Inc. |
Novel compound that inhibits tnf-alpha generation and inflammasome activity and preparation method therefor
|